Radiation therapy for inflammatory breast cancer

Area of Science:

• Oncology
• Medical Research

Background:

• Inflammatory Breast Cancer (IBC) is a rare, aggressive form of breast cancer with a poor prognosis.
• Effective management necessitates integrated care and early multidisciplinary team evaluation to determine optimal treatment strategies.

Purpose of the Study:

• To outline the standard and debated treatment approaches for Inflammatory Breast Cancer.
• To emphasize the importance of neoadjuvant therapy and multimodal treatment in improving outcomes.

Main Methods:

• Review of current treatment recommendations and practices for IBC.
• Discussion of the role of neoadjuvant systemic therapy, surgery (mastectomy vs. breast-conserving surgery), and radiotherapy.

Main Results:

• Neoadjuvant systemic therapy is the standard of care for initially unresectable IBC.
• Pathological complete response (pCR) is a key indicator for proceeding to definitive local therapy.
• Mastectomy followed by radiotherapy is common, but breast-conserving surgery in select cases remains under investigation.

Conclusions:

• A trimodality treatment approach (neoadjuvant therapy, surgery, radiotherapy) is generally recommended for IBC.
• Further research is warranted to refine treatment strategies and improve survival rates for this aggressive cancer.